Replek Overview

  • Founded
  • 1945

  • Status
  • Public

  • Employees
  • 479

  • Stock Symbol
  • REPL

Stock Symbol
  • Share Price
  • $1.44K

  • (As of Friday Closing)

Replek General Information


Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Other Devices and Supplies
Stock Exchange
Primary Office
  • Kozle st. 188
  • Skopje, 1000
  • Macedonia
+389 02 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Replek Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.44K $1.47K $1.39K - $2.04K $37.4M 25.9K 10.00 $42.47

Replek Financials Summary

In Thousands,
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 39,290 50,207 37,167
Revenue 22,239 23,892 23,322 18,942
EBITDA 2,279 3,265 3,648 2,796
Net Income 1,101 2,565 3,003 2,418
Total Assets 35,748 38,688 41,948 34,637
Total Debt 2,912 3,455 3,944 1,892
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Replek Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial